RetractedArticleOncotarget2017

MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.

Yanqing Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.